Verified earnings results
Verrica Pharmaceuticals Q3 2026 Earnings Results
Direct answer
Verrica Pharmaceuticals reported Q3 2026 results on November 12, 2026.
Revenue was 6,914,000. EPS missed the estimate by 14.33%.
The result is verified against Verified earnings source.
Verified earnings source
Get free Verrica Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Earnings date
- November 12, 2026
- Reported timing
- After the US market closes
- EPS estimate
- -0.5073
- Reported EPS
- -0.58
- Revenue
- 6,914,000
- EPS surprise
- EPS missed the estimate by 14.33%.
Explore related company data
Read the frequently asked questions.
When did Verrica Pharmaceuticals report Q3 2026 earnings?
Verrica Pharmaceuticals reported on November 12, 2026. The reported timing was after the us market closes.
What is the available EPS estimate for Verrica Pharmaceuticals?
The verified record provides an EPS estimate of -0.5073.
Has Verrica Pharmaceuticals reported the Q3 2026 result?
Revenue was 6,914,000. EPS missed the estimate by 14.33%.
Which source supports this Verrica Pharmaceuticals earnings record?
The earnings record identifies Verified earnings source as its source. Missing values are not estimated.